Form 8-K - Current report:
SEC Accession No. 0001104659-21-077960
Filing Date
2021-06-08
Accepted
2021-06-08 07:00:50
Documents
14
Period of Report
2021-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119052d1_8k.htm   iXBRL 8-K 24332
2 EXHIBIT 99.1 tm2119052d1_ex99-1.htm EX-99.1 18630
6 GRAPHIC tm2119052d1_ex99-1img01.jpg GRAPHIC 5509
  Complete submission text file 0001104659-21-077960.txt   229294

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fold-20210608.xsd EX-101.SCH 3217
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fold-20210608_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fold-20210608_pre.xml EX-101.PRE 22731
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2119052d1_8k_htm.xml XML 3487
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33497 | Film No.: 211001231
SIC: 2834 Pharmaceutical Preparations